Business Description
![Arbutus Biopharma Corp Arbutus Biopharma Corp logo](https://static.gurufocus.com/logos/0C00000IJJ.png?14)
Arbutus Biopharma Corp
NAICS : 325412
SIC : 3741
ISIN : CA03879J1003
Description
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 76.79 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -2.96 | |||||
Beneish M-Score | -2.59 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.2 | |||||
3-Year EBITDA Growth Rate | 17.5 | |||||
3-Year EPS without NRI Growth Rate | 23.7 | |||||
3-Year FCF Growth Rate | 8.4 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.42 | |||||
9-Day RSI | 43.73 | |||||
14-Day RSI | 46.78 | |||||
6-1 Month Momentum % | 48.59 | |||||
12-1 Month Momentum % | 37.97 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.69 | |||||
Quick Ratio | 6.69 | |||||
Cash Ratio | 6.37 | |||||
Days Sales Outstanding | 63.88 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -23.2 | |||||
Shareholder Yield % | -5.43 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -616.64 | |||||
Net Margin % | -572.81 | |||||
FCF Margin % | -606.47 | |||||
ROE % | -60.12 | |||||
ROA % | -45.28 | |||||
ROIC % | -238 | |||||
ROC (Joel Greenblatt) % | -1163.35 | |||||
ROCE % | -52.42 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 39.23 | |||||
PB Ratio | 4.81 | |||||
Price-to-Tangible-Book | 4.73 | |||||
EV-to-EBIT | -6.09 | |||||
EV-to-EBITDA | -6.21 | |||||
EV-to-Revenue | 34.78 | |||||
EV-to-Forward-Revenue | 70.37 | |||||
EV-to-FCF | -5.7 | |||||
Price-to-Median-PS-Value | 1.8 | |||||
Price-to-Net-Current-Asset-Value | 5.47 | |||||
Price-to-Net-Cash | 5.81 | |||||
Earnings Yield (Greenblatt) % | -16.41 | |||||
FCF Yield % | -13.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arbutus Biopharma Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 12.034 | ||
EPS (TTM) (€) | -0.406 | ||
Beta | 1.03 | ||
Volatility % | 43.03 | ||
14-Day RSI | 46.78 | ||
14-Day ATR (€) | 0.086404 | ||
20-Day SMA (€) | 2.9245 | ||
12-1 Month Momentum % | 37.97 | ||
52-Week Range (€) | 1.534 - 3.294 | ||
Shares Outstanding (Mil) | 188.72 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Arbutus Biopharma Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Arbutus Biopharma Corp Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Arbutus Biopharma Corp Frequently Asked Questions
What is Arbutus Biopharma Corp(STU:I9DN)'s stock price today?
The current price of STU:I9DN is €2.79. The 52 week high of STU:I9DN is €3.29 and 52 week low is €1.53.
When is next earnings date of Arbutus Biopharma Corp(STU:I9DN)?
The next earnings date of Arbutus Biopharma Corp(STU:I9DN) is 2024-08-02 Est..
Does Arbutus Biopharma Corp(STU:I9DN) pay dividends? If so, how much?
Arbutus Biopharma Corp(STU:I9DN) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |